Proxy Votes Now

Home › Funds › Brighthouse › MetLife Russell 2000 Index Portfolio

MetLife Russell 2000 Index Portfolio proxy voting record 2025-2026

Fund family: Brighthouse · Filed by Brighthouse Funds Trust II (CIK 710826) · SEC series S000006525

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 12,511 with, 1,879 against, 0 abstentions (not counted as with management); 58 items carried no recommendation; 14 split votes are in neither count. Shareholder proposals: 26 FOR, 11 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Brighthouse as a whole

The same two figures as Brighthouse’s manager page (247,741 ballot items across 83 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsBrighthouseItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)86.9%13,92976.3%204,500
Backed environmental and social shareholder proposals at US companiesn/a612.8%1,182

Where this fund voted differently from most Brighthouse funds

Each ballot item this fund voted is set against the votes of the other Brighthouse funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Brighthouse funds on 381 items (11.7% of the 3,261 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
SkyWest, Inc.2026-05-05Shareholder A shareholder proposal regarding collective bargaining policy.ForABSTAIN or AGAINST — 5 of 5 Brighthouse fundsAgainst—
Marex Group plc2026-05-21Amend Articles of AssociationAgainstFOR — 4 of 4 Brighthouse fundsFor—
Marex Group plc2026-05-21Approve Capital Reduction by Cancellation and Extinguishment of the Deferred SharesAgainstFOR — 4 of 4 Brighthouse fundsFor—
Marex Group plc2026-05-21Approve Capital Reduction by Cancellation and Extinguishment of the Scheme SharesAgainstFOR — 4 of 4 Brighthouse fundsFor—
ArcBest Corporation2026-04-24Shareholder A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting.ForABSTAIN or AGAINST — 4 of 4 Brighthouse fundsAgainst—
Alignment Healthcare, Inc.2026-06-04Election of Directors: David HodgsonWithholdFOR — 4 of 4 Brighthouse fundsForElected, 60.8% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jacqueline KosecoffWithholdFOR — 4 of 4 Brighthouse fundsForElected, 76.1% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jody BilneyWithholdFOR — 4 of 4 Brighthouse fundsForElected, 76.1% support
Marex Group Plc2026-05-21Approve Scheme of ArrangementAgainstFOR — 4 of 4 Brighthouse fundsFor—
Guardant Health, Inc.2026-06-17Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers.ForABSTAIN — 3 of 3 Brighthouse fundsFor—
Tarsus Pharmaceuticals, Inc.2026-06-25To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: David E.I. PyottForWITHHOLD — 3 of 3 Brighthouse fundsForElected, 96.7% support
Wave Life Sciences Ltd.2025-08-05To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement.AgainstFOR — 3 of 3 Brighthouse fundsForApproved, 81.1% support
Wave Life Sciences Ltd.2025-08-05To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.AgainstFOR — 3 of 3 Brighthouse fundsForApproved, 78.2% support
Madrigal Pharmaceuticals, Inc.2026-06-172 wordings Re-election of Class I directors: Julian BakerForWITHHOLD — 4 of 5 Brighthouse fundsForElected, 88.6% support
Meritage Homes Corporation2026-05-21Shareholder Shareholder proposal to improve shareholder ability to call for a special shareholder meeting.ForABSTAIN or AGAINST — 4 of 5 Brighthouse fundsAgainstNot approved, 25.6% support
Asbury Automotive Group, Inc.2026-05-04Shareholder Stockholder proposal regarding special stockholder meetings.ForAGAINST or ABSTAIN — 4 of 5 Brighthouse fundsAgainstNot approved, 23.8% support
Apogee Therapeutics, Inc.2026-06-09Election of Class III Directors for terms expiring in 2029: William (BJ) Jones, Jr.WithholdFOR — 4 of 5 Brighthouse fundsForPassed (calculated), 81.5% support
FirstCash Holdings, Inc.2026-06-09Election of Directors: Daniel E. BerceForABSTAIN or AGAINST — 5 of 7 Brighthouse fundsForPassed (calculated), 94.3% support
FirstCash Holdings, Inc.2026-06-09Election of Directors: Mikel D. FaulknerForABSTAIN or AGAINST — 5 of 7 Brighthouse fundsForPassed (calculated), 92.4% support
FirstCash Holdings, Inc.2026-06-09Election of Directors: Randel G. OwenForABSTAIN or AGAINST — 5 of 7 Brighthouse fundsForPassed (calculated), 87.7% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Robert E. Knowling, Jr.ForWITHHOLD — 5 of 7 Brighthouse fundsForElected, 96.1% support
Glaukos Corporation2026-05-28Approval, on an advisory basis, of the compensation of the Company's named executive officers.ForABSTAIN or AGAINST — 5 of 8 Brighthouse fundsForPassed (calculated), 91.8% support
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Michael T. MillerForAGAINST or ABSTAIN — 5 of 8 Brighthouse fundsForElected, 96.1% support
Calix, Inc.2026-05-14Shareholder To hold an advisory vote on a stockholder proposal relating to a simple majority vote.ForABSTAIN or AGAINST — 5 of 8 Brighthouse fundsAgainstPassed (calculated), 90.8% support
Zurn Elkay Water Solutions Corporation2026-04-30Ratification of the selection of Ernst & Young LLP as Zurn Elkay's independent registered public accounting firm for the year ending December 31, 2026.ForABSTAIN — 3 of 4 Brighthouse fundsForPassed (calculated), 98.1% support
Show all 381
Items 26 to 381.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William FaireyWithholdFOR — 3 of 4 Brighthouse fundsForElected, 86.8% support
FormFactor, Inc.2026-05-15Amendment to FormFactor's Certificate of Incorporation to Reflect New Delaware Law Provisions Regarding Officer Exculpation.ForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsForApproved, 87.7% support
Scholar Rock Holding Corporation2026-06-04To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: David HallalWithholdFOR — 3 of 4 Brighthouse fundsForElected, 86.5% support
Granite Construction Incorporated2026-06-04Election of Directors: Carlos M. HernandezForABSTAIN or AGAINST — 3 of 4 Brighthouse fundsForPassed (calculated), 96.1% support
Granite Construction Incorporated2026-06-04Election of Directors: Celeste B. MastinForABSTAIN or AGAINST — 3 of 4 Brighthouse fundsForPassed (calculated), 94.6% support
VSE Corporation2026-05-07Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.ForAGAINST or ABSTAIN — 3 of 4 Brighthouse fundsForApproved, 78.4% support
Edgewise Therapeutics, Inc.2026-06-04Conduct an advisory vote on the compensation of our named executive officers.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 96.1% support
Edgewise Therapeutics, Inc.2026-06-04Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 100.0% support
AAR Corp.2025-09-16Election of four directors named in the proxy statement: Jeffrey N. EdwardsForAGAINST or ABSTAIN — 3 of 4 Brighthouse fundsForElected, 82.1% support
OneSpaWorld Holdings Limited2026-06-03Election of Directors: Lisa MyersForWITHHOLD — 3 of 4 Brighthouse fundsForPassed (calculated), 85.4% support
OneSpaWorld Holdings Limited2026-06-03Election of Directors: Maryam BanikarimForWITHHOLD — 3 of 4 Brighthouse fundsForPassed (calculated), 81.2% support
OSI Systems, Inc.2025-12-11Election of Directors: Ajay MehraForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsForElected, 97.4% support
OSI Systems, Inc.2025-12-11Election of Directors: Deepak ChopraForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsForElected, 97.1% support
OSI Systems, Inc.2025-12-11Election of Directors: Gerald ChizeverForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsForElected, 89.8% support
OSI Systems, Inc.2025-12-11Election of Directors: Kelli BernardForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsForElected, 93.6% support
Extreme Networks, Inc.2025-11-12Approve an amendment and restatement of the Extreme Networks, Inc. 2013 Equity Incentive plan to add 6,800,000 shares of our common stock to those reserved for issuance under the plan.ForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsFor—
Vera Therapeutics, Inc.2026-05-21To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 95.9% support
Vera Therapeutics, Inc.2026-05-21To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 99.9% support
The Bancorp, Inc.2026-05-27Election of ten directors to serve for a term of one year until the 2027 annual meeting of stockholders: Cheryl D. CreuzotForABSTAIN or AGAINST — 3 of 4 Brighthouse fundsForPassed (calculated), 96.2% support
The Bancorp, Inc.2026-05-27Election of ten directors to serve for a term of one year until the 2027 annual meeting of stockholders: Matthew N. CohnForABSTAIN or AGAINST — 3 of 4 Brighthouse fundsForPassed (calculated), 97.2% support
The Bancorp, Inc.2026-05-27Election of ten directors to serve for a term of one year until the 2027 annual meeting of stockholders: William H. LambForABSTAIN or AGAINST — 3 of 4 Brighthouse fundsForPassed (calculated), 96.8% support
Ocular Therapeutix, Inc.2026-06-10To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation.ForABSTAIN — 3 of 4 Brighthouse fundsForPassed (calculated), 96.4% support
Rambus Inc.2026-04-23Election of Directors: Charles KissnerForAGAINST or ABSTAIN — 6 of 11 Brighthouse fundsForPassed (calculated), 85.5% support
Kratos Defense & Security Solutions, Inc.2026-05-12To approve an amendment to the Company's Certificate of Incorporation to provide for officer exculpation.ForABSTAIN or AGAINST — 6 of 11 Brighthouse fundsForApproved, 88.6% support
FirstCash Holdings, Inc.2026-06-09Approve, by non-binding vote, the compensation of named executive officers as described in the Proxy Statement.ForABSTAIN — 4 of 7 Brighthouse fundsForApproved, 96.7% support
FirstCash Holdings, Inc.2026-06-09To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026.ForABSTAIN — 4 of 7 Brighthouse fundsForApproved, 97.5% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Aida M. AlvarezForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 97.8% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Allison LawrenceForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 98.1% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Joseph A. VerbruggeForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 97.9% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Liza McFaddenForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 93.6% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Ralph SmithForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 98.2% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Steven B. FinkForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 95.2% support
Madrigal Pharmaceuticals, Inc.2026-06-17Advisory vote to approve executive compensationForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 97.1% support
Madrigal Pharmaceuticals, Inc.2026-06-17Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase PlanForAGAINST — 3 of 5 Brighthouse fundsFor—
Madrigal Pharmaceuticals, Inc.2026-06-17Re-election of Class I directors: Daniel BrennanForWITHHOLD — 3 of 5 Brighthouse fundsForElected, 99.4% support
Madrigal Pharmaceuticals, Inc.2026-06-17To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 99.8% support
Krystal Biotech, Inc.2026-05-15Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 95.6% support
Krystal Biotech, Inc.2026-05-15To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 99.9% support
Protagonist Therapeutics, Inc.2026-06-17To approve the adoption of the Company's 2026 Equity Incentive Plan.AgainstFOR — 3 of 5 Brighthouse fundsForApproved, 84.4% support
Semtech Corporation2026-06-04Approve the amendment and restatement of the Semtech Corporation 2017 Long-Term Equity Incentive Plan.ForABSTAIN — 3 of 5 Brighthouse fundsForPassed (calculated), 98.0% support
Semtech Corporation2026-06-04Approve, on an advisory basis, the Company's executive compensation.ForABSTAIN — 3 of 5 Brighthouse fundsForPassed (calculated), 97.6% support
Semtech Corporation2026-06-04Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Gregory M. FischerForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 99.6% support
Semtech Corporation2026-06-04Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Hong Q. HouForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 99.7% support
Semtech Corporation2026-06-04Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Julie G. RuehlForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 99.7% support
Semtech Corporation2026-06-04Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Martin S.J. BurvillForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 99.1% support
Semtech Corporation2026-06-04Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Paul V. Walsh, Jr.ForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 99.5% support
Semtech Corporation2026-06-04Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Paula LuPrioreForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 99.6% support
Semtech Corporation2026-06-04Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Rodolpho C. CardenutoForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 99.5% support
Semtech Corporation2026-06-04Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Saar GillaiForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 99.3% support
Semtech Corporation2026-06-04Elect nine directors nominated by the Company's Board of Directors and named in the Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Ye Jane LiForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 98.8% support
Semtech Corporation2026-06-04Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for fiscal year 2027.ForABSTAIN — 3 of 5 Brighthouse fundsForPassed (calculated), 99.6% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Amin N. MarediaForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Edward N. AntoianForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForPassed (calculated), 97.6% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Harry S. Cherken, Jr.ForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForPassed (calculated), 98.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: John C. MullikenForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForPassed (calculated), 97.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Kelly CampbellForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForPassed (calculated), 99.3% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Mary C. EganForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Todd R. MorgenfeldForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForPassed (calculated), 99.1% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Wesley S. McDonaldForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForPassed (calculated), 98.3% support
Rhythm Pharmaceuticals, Inc.2026-06-24Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirrWithholdFOR — 3 of 5 Brighthouse fundsForPassed (calculated), 85.9% support
FormFactor, Inc.2026-05-15Election of Directors: Brian WhiteForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.3% support
FormFactor, Inc.2026-05-15Election of Directors: Jorge TitingerForABSTAIN — 3 of 5 Brighthouse fundsForElected, 98.0% support
FormFactor, Inc.2026-05-15Election of Directors: Kelley Steven-WaissForABSTAIN — 3 of 5 Brighthouse fundsForElected, 98.5% support
FormFactor, Inc.2026-05-15Election of Directors: Michael D. SlessorForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.4% support
FormFactor, Inc.2026-05-15Election of Directors: Rebeca Obregon JimenezForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.8% support
FormFactor, Inc.2026-05-15Election of Directors: Sheri RhodesForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.8% support
FormFactor, Inc.2026-05-15Election of Directors: Thomas St. DennisForABSTAIN — 3 of 5 Brighthouse fundsForElected, 95.4% support
Dianthus Therapeutics, Inc.2026-05-21To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorgeWithholdFOR — 3 of 5 Brighthouse fundsForPassed (calculated), 80.6% support
CorVel Corporation2025-08-07To approve the 2025 Stock Incentive Plan.AgainstFOR — 3 of 5 Brighthouse fundsForPassed (calculated), 84.0% support
Chesapeake Utilities Corporation2026-05-06Approve on an advisory non-binding basis the compensation of the Company's Named Executive Officers.ForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsFor—
Group 1 Automotive, Inc.2026-05-12Shareholder Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting.ForAGAINST or ABSTAIN — 3 of 5 Brighthouse fundsAgainstNot approved, 25.3% support
AtriCure, Inc.2026-05-18Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 95.9% support
AtriCure, Inc.2026-05-18Election of Directors: B. Kristine JohnsonForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.0% support
AtriCure, Inc.2026-05-18Election of Directors: Deborah H. TelmanForABSTAIN — 3 of 5 Brighthouse fundsForElected, 97.2% support
AtriCure, Inc.2026-05-18Election of Directors: Karen N. PrangeForABSTAIN — 3 of 5 Brighthouse fundsForElected, 98.6% support
AtriCure, Inc.2026-05-18Election of Directors: Maggie YuenForABSTAIN — 3 of 5 Brighthouse fundsForElected, 98.4% support
AtriCure, Inc.2026-05-18Election of Directors: Michael H. CarrelForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.4% support
AtriCure, Inc.2026-05-18Election of Directors: Regina E. GrovesForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.4% support
AtriCure, Inc.2026-05-18Election of Directors: Robert S. WhiteForABSTAIN — 3 of 5 Brighthouse fundsForElected, 97.4% support
AtriCure, Inc.2026-05-18Election of Directors: Shlomo NachmanForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.4% support
AtriCure, Inc.2026-05-18Election of Directors: Sven A. WehrweinForABSTAIN — 3 of 5 Brighthouse fundsForElected, 98.4% support
AtriCure, Inc.2026-05-18Proposal to approve an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000.ForAGAINST — 3 of 5 Brighthouse fundsFor—
AtriCure, Inc.2026-05-18Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000.ForABSTAIN — 3 of 5 Brighthouse fundsFor—
AtriCure, Inc.2026-05-18Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 94.9% support
Constellium SE2026-05-21Re-appointment of Mr. John Ormerod as a director for a term of three yearsForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForPassed (calculated), 83.8% support
Blue Bird Corporation2026-03-11To approve an amendment to our certificate of incorporation to provide for limitation of liability of certain officers for certain breaches of fiduciary duty as permitted under Delaware law.ForAGAINST or ABSTAIN — 3 of 5 Brighthouse fundsForApproved, 86.2% support
Ocular Therapeutix, Inc.2026-06-10To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares.ForABSTAIN — 3 of 5 Brighthouse fundsFor—
Ocular Therapeutix, Inc.2026-06-10To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 98.9% support
Zeta Global Holdings Corp.2026-06-16Approval, on an advisory (non-binding) basis, of the compensation of our named executive officersForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 94.9% support
Zeta Global Holdings Corp.2026-06-16Election of Directors: Robert NiehausForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 97.1% support
Zeta Global Holdings Corp.2026-06-16Election of Directors: William LandmanForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 93.7% support
Zeta Global Holdings Corp.2026-06-16Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 100.0% support
Silicon Laboratories Inc.2026-04-23To approve amendments to the 2009 Stock Incentive Plan; andAgainstFOR — 2 of 3 Brighthouse fundsForPassed (calculated), 78.0% support
Compass, Inc.2026-05-14Election of Class II Directors: Allan LeinwandForABSTAIN — 2 of 3 Brighthouse fundsForElected, 97.0% support
Compass, Inc.2026-05-14Election of Class II Directors: Pamela Thomas-GrahamForABSTAIN — 2 of 3 Brighthouse fundsForElected, 96.7% support
Ligand Pharmaceuticals Incorporated2026-06-05Election of Directors: Jason M. AryehForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 82.0% support
Ligand Pharmaceuticals Incorporated2026-06-05Election of Directors: John W. Kozarich, Ph.D.ForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 92.7% support
Ligand Pharmaceuticals Incorporated2026-06-05Election of Directors: Nancy R. Gray, Ph.D.ForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 96.5% support
Super Group (SGHC) Limited2026-06-25Authorize Market Purchases of Company SharesAgainstFOR — 2 of 3 Brighthouse fundsFor—
Super Group (SGHC) Limited2026-06-25Elect Director John Le PoidevinForAGAINST — 2 of 3 Brighthouse fundsFor—
Super Group (SGHC) Limited2026-06-25Elect Director Jonathan JosselForAGAINST — 2 of 3 Brighthouse fundsFor—
Super Group (SGHC) Limited2026-06-25Elect Director Robert James DutnallForAGAINST — 2 of 3 Brighthouse fundsFor—
Transocean Ltd.2026-05-22Advisory Vote to Approve the Swiss Statutory Report on Non-Financial Matters for Fiscal Year 2025ForABSTAIN — 2 of 3 Brighthouse fundsFor—
SSR Mining Inc.2026-05-07To approve on an advisory (non-binding) basis, the compensation of the Company's named executive officers disclosed in this Proxy Statement.ForAGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 54.3% support
Merit Medical Systems, Inc.2026-05-13The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term)ForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForElected, 97.6% support
Merit Medical Systems, Inc.2026-05-13The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term)ForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 97.8% support
Herc Holdings Inc.2026-05-14Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Jean K. HolleyForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 97.4% support
Herc Holdings Inc.2026-05-14Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Michael A. KellyForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 91.5% support
Herc Holdings Inc.2026-05-14Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Patrick D. CampbellForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 97.6% support
Herc Holdings Inc.2026-05-14Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Rakesh SachdevForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 89.3% support
BGC Group, Inc.2025-11-12Approval of the ratification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for fiscal year 2025.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.9% support
CRISPR Therapeutics AG2026-06-04Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan.AgainstFOR — 2 of 3 Brighthouse fundsForApproved, 88.1% support
CRISPR Therapeutics AG2026-06-04Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.AgainstFOR — 2 of 3 Brighthouse fundsFor—
CRISPR Therapeutics AG2026-06-04Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.AgainstFOR — 2 of 3 Brighthouse fundsFor—
CRISPR Therapeutics AG2026-06-04Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027.AgainstFOR — 2 of 3 Brighthouse fundsFor—
CRISPR Therapeutics AG2026-06-04Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026.AgainstFOR — 2 of 3 Brighthouse fundsFor—
CRISPR Therapeutics AG2026-06-04Non-binding advisory vote on the 2025 Compensation Report.AgainstFOR — 2 of 3 Brighthouse fundsFor—
CRISPR Therapeutics AG2026-06-04Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.AgainstFOR — 2 of 3 Brighthouse fundsForApproved, 69.4% support
Erasca, Inc.2026-06-26To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 100.0% support
Synaptics Incorporated2025-10-28Proposal for the Election of Directors: James L. WhimsForABSTAIN — 2 of 3 Brighthouse fundsForElected, 92.3% support
Synaptics Incorporated2025-10-28Proposal for the Election of Directors: Jeffrey D. BuchananForABSTAIN — 2 of 3 Brighthouse fundsForElected, 92.1% support
Synaptics Incorporated2025-10-28Proposal for the Election of Directors: Keith B. GeeslinForABSTAIN — 2 of 3 Brighthouse fundsForElected, 92.2% support
Synaptics Incorporated2025-10-28Proposal for the Election of Directors: Patricia KummrowForABSTAIN — 2 of 3 Brighthouse fundsForElected, 90.0% support
Synaptics Incorporated2025-10-28Proposal for the Election of Directors: Rahul PatelForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.1% support
Synaptics Incorporated2025-10-28Proposal for the Election of Directors: Vivie LeeForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.3% support
Synaptics Incorporated2025-10-28Proposal to approve the Company's amended and restated 2019 Employee Stock Purchase Plan.ForAGAINST — 2 of 3 Brighthouse fundsForApproved, 99.7% support
Synaptics Incorporated2025-10-28Proposal to approve, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 96.0% support
Synaptics Incorporated2025-10-28Proposal to ratify the appointment of KPMG LLP, an independent registered public accounting firm, as the Company's independent auditor for the fiscal year ending June 27, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 98.7% support
Powell Industries, Inc.2026-02-18To elect two (2) members of the Company's Board of Directors, with terms to expire in 2029: Alaina K. BrooksForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 94.3% support
Powell Industries, Inc.2026-02-18To elect two (2) members of the Company's Board of Directors, with terms to expire in 2029: Katheryn B. CurtisForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 92.7% support
ServisFirst Bancshares, Inc.2026-05-18To elect the following persons to serve as directors for a one-year term until the 2027 Annual Meeting: Betsy Bugg HollowayForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 97.9% support
ServisFirst Bancshares, Inc.2026-05-18To elect the following persons to serve as directors for a one-year term until the 2027 Annual Meeting: Christopher J. MettlerForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 97.9% support
ServisFirst Bancshares, Inc.2026-05-18To elect the following persons to serve as directors for a one-year term until the 2027 Annual Meeting: Irma L. TuderForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 97.7% support
ServisFirst Bancshares, Inc.2026-05-18To elect the following persons to serve as directors for a one-year term until the 2027 Annual Meeting: J. Richard CashioForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 94.3% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: Aylwin LewisForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 73.2% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: Christopher PappasForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.5% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: Debra Walton-RuskinForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.7% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: John PappasForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.8% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: Lester OwensForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.7% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: Richard N. PeretzForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.7% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: Steven F. GoldstoneForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.3% support
The Chefs' Warehouse, Inc.2026-05-08To ratify the selection of BDO USA, P.C. as our Independent registered public accounting firm for the fiscal year ending December 25, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 98.4% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Alan FrankForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.1% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Allen C. PuwalskiForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.2% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Eli H. MillerForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.2% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Jennifer R. WhipForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.9% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Joseph OttingForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.1% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Marshall LuxForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.0% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Milton BerlinskiForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.0% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Steven T. MnuchinForABSTAIN — 2 of 3 Brighthouse fundsForElected, 96.0% support
iRhythm Holdings, Inc.2026-05-27To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Bruce BodakenWithholdFOR — 2 of 3 Brighthouse fundsForElected, 74.1% support
Integer Holdings Corporation2026-05-20To approve, in an advisory non-binding vote, the compensation of our named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.6% support
Integer Holdings Corporation2026-05-20To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.3% support
Franklin Electric Co., Inc.2026-05-08Approve, on an advisory basis, the frequency of future votes on the compensation of the Named Executive Officers as disclosed in the Proxy Statement.ForABSTAIN — 2 of 3 Brighthouse fundsFor—
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Jody A. MarkopoulosForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: John W. KuoForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Kenneth C. BockhorstForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Lawrence D. KingsleyForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Robert A. CascellaForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 100.0% support
AAR Corp.2025-09-16Election of four directors named in the proxy statement: Ellen M. LordForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForElected, 93.7% support
AAR Corp.2025-09-16Election of four directors named in the proxy statement: Marc J. WalfishForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForElected, 90.9% support
The St. Joe Company2026-05-12Approval, on an advisory basis, of the compensation of our named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 98.0% support
The St. Joe Company2026-05-12Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.9% support
Solaris Energy Infrastructure, Inc.2026-05-15Approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2025.ForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 86.4% support
Core Scientific, Inc.2026-05-12Election of Directors: Yadin RozovForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 96.8% support
Xenon Pharmaceuticals Inc.2026-06-02To approve the Corporation's 2026 Equity Incentive Plan;AgainstFOR — 2 of 3 Brighthouse fundsForApproved, 68.0% support
The Vita Coco Company, Inc.2026-06-03Election of Class II Directors: Kenneth SadowskyWithholdFOR — 2 of 3 Brighthouse fundsForPassed (calculated), 80.8% support
The Vita Coco Company, Inc.2026-06-03Election of Class II Directors: Michael KirbanForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 93.8% support
NCR Atleos Corporation2026-05-21Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Duncan L. NiedeForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.7% support
NCR Atleos Corporation2026-05-21Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Frank A. NatoliForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.1% support
NCR Atleos Corporation2026-05-21Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Jeffry H. von GForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.6% support
NCR Atleos Corporation2026-05-21Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Joseph E. ReeceForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.6% support
NCR Atleos Corporation2026-05-21Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Mary Ellen BakeForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 95.0% support
NCR Atleos Corporation2026-05-21Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Odilon Almeida,ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.4% support
NCR Atleos Corporation2026-05-21Consider and vote upon the election of seven individuals to the Board of Directors as described in these proxy materials, each to serve until the next annual meeting of stockholders following his or her election and until his or her respective successor is duly elected and qualifies: Timothy C. OlivForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.8% support
Par Pacific Holdings, Inc.2026-04-30To approve the Par Pacific Holdings, Inc. 2026 Long-Term Incentive Plan.AgainstFOR — 2 of 3 Brighthouse fundsForPassed (calculated), 70.6% support
The GEO Group, Inc.2026-04-28Advisory vote to approve named executive officer compensation.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 71.6% support
The GEO Group, Inc.2026-04-28Election of Directors: Donna Arduin KauranenForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.4% support
The GEO Group, Inc.2026-04-28Election of Directors: George C. ZoleyForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.4% support
The GEO Group, Inc.2026-04-28Election of Directors: Jack BrewerForABSTAIN — 2 of 3 Brighthouse fundsForElected, 78.5% support
The GEO Group, Inc.2026-04-28Election of Directors: Julie Myers WoodForABSTAIN — 2 of 3 Brighthouse fundsForElected, 95.5% support
The GEO Group, Inc.2026-04-28Election of Directors: Lindsay L. KorenForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.2% support
The GEO Group, Inc.2026-04-28Election of Directors: Scott M. KernanForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.2% support
The GEO Group, Inc.2026-04-28Election of Directors: Thomas C. BartzokisForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.3% support
The GEO Group, Inc.2026-04-28To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accountants for the 2026 fiscal year.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.3% support
Acadian Asset Management Inc.2026-06-11Advisory vote to approve executive compensation.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 97.6% support
Acadian Asset Management Inc.2026-06-11Election of Directors: Andrew KimForABSTAIN — 2 of 3 Brighthouse fundsForElected, 85.0% support
Acadian Asset Management Inc.2026-06-11Election of Directors: Barbara TrebbiForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.3% support
Acadian Asset Management Inc.2026-06-11Election of Directors: John PaulsonForABSTAIN — 2 of 3 Brighthouse fundsForElected, 90.6% support
Acadian Asset Management Inc.2026-06-11Election of Directors: Kelly YoungForABSTAIN — 2 of 3 Brighthouse fundsForElected, 97.3% support
Acadian Asset Management Inc.2026-06-11Election of Directors: Robert ChersiForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.0% support
Acadian Asset Management Inc.2026-06-11Ratification of the appointment of KPMG LLP as the registered public accounting firm of Acadian Asset Management Inc.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.8% support
Seacoast Banking Corporation of Florida2026-05-20Advisory (Non-binding) Vote on Compensation of Named Executive OfficersForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForApproved, 98.0% support
Indivior Pharmaceuticals, Inc.2026-05-13To approve, on an advisory basis, the compensation of our named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.6% support
Indivior Pharmaceuticals, Inc.2026-05-13To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.8% support
Diodes Incorporated2026-05-11To elect six persons to the Board of Directors of the Company, each to serve until the next annual meeting of stockholders and until their respective successors have been elected and qualified: Huey-Jen (Jenny) SuForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 89.8% support
WD-40 Company2025-12-12To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Anne G. SaundersForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.1% support
WD-40 Company2025-12-12To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Cynthia B. BurksForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.0% support
WD-40 Company2025-12-12To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Daniel T. CarterForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.2% support
WD-40 Company2025-12-12To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: David B. PendarvisForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.0% support
WD-40 Company2025-12-12To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Edward O. Magee, Jr.ForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.1% support
WD-40 Company2025-12-12To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Eric P. EtchartForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.0% support
WD-40 Company2025-12-12To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Graciela I. MonteagudoForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.0% support
WD-40 Company2025-12-12To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Lara L. LeeForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.9% support
WD-40 Company2025-12-12To elect a Board of Directors for the ensuing year and until their successors are elected and qualified: Steven A. BrassForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.1% support
Shake Shack Inc.2026-06-10Approval, on an advisory basis, of the compensation of our Named Executive Officers.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 93.7% support
Shake Shack Inc.2026-06-10Ratification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.7% support
The Marzetti Company2025-11-19To approve, by non-binding vote, the compensation of the Corporation's named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.1% support
ArcBest Corporation2026-04-24Election of Directors: Ann G. BordelonForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.9% support
ArcBest Corporation2026-04-24Election of Directors: Bobby K. GeorgeForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.9% support
ArcBest Corporation2026-04-24Election of Directors: Chris T. SultemeierForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.9% support
ArcBest Corporation2026-04-24Election of Directors: Eduardo F. ConradoForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.4% support
ArcBest Corporation2026-04-24Election of Directors: Janice E. StippForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.5% support
ArcBest Corporation2026-04-24Election of Directors: Judy R. McReynoldsForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.2% support
ArcBest Corporation2026-04-24Election of Directors: Michael P. HoganForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.5% support
ArcBest Corporation2026-04-24Election of Directors: Salvatore A. AbbateForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.9% support
ArcBest Corporation2026-04-24Election of Directors: Seth K. RunserForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.9% support
ArcBest Corporation2026-04-24Election of Directors: Thom S. AlbrechtForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.9% support
Banc of California, Inc.2026-05-06Approval of the Company's Second Amended and Restated 2018 Omnibus Stock Incentive Plan.ForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForApproved, 98.1% support
Kohl's Corporation2026-05-20Management Proposal: Approve the Amended and Restated Kohl's Corporation 2024 Long-Term Compensation Plan.ForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 95.4% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Denis G. SuggsForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 93.5% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. ForbesForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 92.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. CerulliForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 83.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: M. Scott WelchForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 93.4% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Natalie A. BrownForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 94.3% support
Progyny, Inc.2026-05-21Election of Directors: Cheryl ScottWithholdFOR — 2 of 3 Brighthouse fundsForElected, 76.2% support
Progyny, Inc.2026-05-21Election of Directors: Kevin GordonWithholdFOR — 2 of 3 Brighthouse fundsForElected, 80.9% support
Progyny, Inc.2026-05-21Election of Directors: Lloyd DeanWithholdFOR — 2 of 3 Brighthouse fundsForElected, 77.1% support
Vericel Corporation2026-04-29Election of Directors: Alan L. RubinoForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 89.7% support
Vericel Corporation2026-04-29Election of Directors: Heidi HagenForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 83.1% support
Vericel Corporation2026-04-29Election of Directors: Paul K. WottonForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 94.8% support
Boise Cascade Company2026-04-30Advisory vote on frequency of advisory vote regarding executive compensation.ForABSTAIN — 2 of 3 Brighthouse fundsFor—
Boise Cascade Company2026-04-30Election of Directors: Amy HumphreysForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.1% support
Boise Cascade Company2026-04-30Election of Directors: Christopher McGowanForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.9% support
Boise Cascade Company2026-04-30Election of Directors: Craig DawsonForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.2% support
Boise Cascade Company2026-04-30Election of Directors: Duane McDougallForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.2% support
Boise Cascade Company2026-04-30Election of Directors: Jeff StromForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.2% support
Boise Cascade Company2026-04-30Election of Directors: Karen GowlandForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 96.6% support
Boise Cascade Company2026-04-30Election of Directors: Kristopher MatulaForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.4% support
Boise Cascade Company2026-04-30Election of Directors: Nate JorgensenForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.0% support
Boise Cascade Company2026-04-30Election of Directors: Steven CooperForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.4% support
Boise Cascade Company2026-04-30Election of Directors: Sue TaylorForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.2% support
Trinity Industries, Inc.2026-05-21Advisory vote to approve named executive officer compensation.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 98.4% support
Trinity Industries, Inc.2026-05-21Election of Directors: Dunia A. ShiveForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.9% support
Trinity Industries, Inc.2026-05-21Election of Directors: E. Jean SavageForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.4% support
Trinity Industries, Inc.2026-05-21Election of Directors: John J. DiezForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.9% support
Trinity Industries, Inc.2026-05-21Election of Directors: Leldon E. EcholsForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.0% support
Trinity Industries, Inc.2026-05-21Election of Directors: Robert C. Biesterfeld Jr.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.6% support
Trinity Industries, Inc.2026-05-21Election of Directors: S. Todd MaclinForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.7% support
Trinity Industries, Inc.2026-05-21Election of Directors: Veena M. LakkundiForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.5% support
Trinity Industries, Inc.2026-05-21Election of Directors: William P. AinsworthForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.2% support
Trinity Industries, Inc.2026-05-21Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 98.3% support
Northern Oil and Gas, Inc.2026-05-21To approve, on an advisory basis, the compensation paid to our named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 96.4% support
Northern Oil and Gas, Inc.2026-05-21To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.8% support
HCI Group, Inc.2026-06-10Ratification of the appointment of Forvis Mazars, LLP as independent registered public accounting firm for fiscal 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.7% support
Interface, Inc.2026-05-19Approval, on an advisory basis, of executive compensation.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.7% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: Catherine M. KilbaneForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.6% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: Catherine MarcusForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.2% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: Christopher G. KennedyForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 96.1% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: Daniel T. HendrixForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 98.2% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: Dwight GibsonForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.8% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: John P. BurkeForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 98.2% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: Joseph KeoughForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.5% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: K. David KohlerForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 97.4% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: Laurel M. HurdForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 98.7% support
Interface, Inc.2026-05-19Election of ten members of the Board of Directors: Robert T. O'BrienForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.5% support
Interface, Inc.2026-05-19Ratification of the appointment of Ernst & Young, LLP as the Company's Independent Registered Public Accounting Firm for 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.9% support
WaFd, Inc.2026-02-03ADVISORY VOTE ON THE COMPENSATION OF WAFD, INC.'S NAMED EXECUTIVE OFFICERS.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 96.1% support
WaFd, Inc.2026-02-03RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITORS.ForABSTAIN — 2 of 3 Brighthouse fundsFor—
Power Integrations, Inc.2026-06-03To approve the amendment and restatement of the Power Integrations, Inc. 2016 Incentive Award Plan to Increase the number of shares reserved for issuance thereunder.AgainstFOR — 2 of 3 Brighthouse fundsForApproved, 83.1% support
NeoGenomics, Inc.2026-05-21Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.ForAGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 83.2% support
NeoGenomics, Inc.2026-05-21Election of the directors named in the proxy statement as set forth below: David B. PerezForAGAINST — 2 of 3 Brighthouse fundsForElected, 96.9% support
NeoGenomics, Inc.2026-05-21Election of the directors named in the proxy statement as set forth below: Dr. Neil GunnForAGAINST — 2 of 3 Brighthouse fundsForElected, 97.3% support
NeoGenomics, Inc.2026-05-21Election of the directors named in the proxy statement as set forth below: Lynn A. TetraultForAGAINST — 2 of 3 Brighthouse fundsForElected, 96.9% support
NeoGenomics, Inc.2026-05-21Election of the directors named in the proxy statement as set forth below: Michael A. KellyForAGAINST — 2 of 3 Brighthouse fundsForElected, 94.9% support
Veracyte, Inc.2026-06-10The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.5% support
Veracyte, Inc.2026-06-10The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent ShaferForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.9% support
Veracyte, Inc.2026-06-10The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav BarrForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.9% support
Veracyte, Inc.2026-06-10The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Evan JonesForABSTAIN — 2 of 3 Brighthouse fundsForElected, 96.6% support
Veracyte, Inc.2026-06-10The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens HolsteinForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.8% support
Veracyte, Inc.2026-06-10The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin EasthamForABSTAIN — 2 of 3 Brighthouse fundsForElected, 97.0% support
Veracyte, Inc.2026-06-10The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna BhanjiForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.4% support
Veracyte, Inc.2026-06-10The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. EpsteinForABSTAIN — 2 of 3 Brighthouse fundsForElected, 93.0% support
Veracyte, Inc.2026-06-10The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom MillerForABSTAIN — 2 of 3 Brighthouse fundsForElected, 99.8% support
Veracyte, Inc.2026-06-10The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.5% support
Harmony Biosciences Holdings, Inc.2026-05-14Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 98.3% support
Vir Biotechnology, Inc.2026-05-26To approve, on an advisory basis, the compensation of the Company's named executive officers.ForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsForApproved, 90.1% support
Kaiser Aluminum Corporation2026-06-04ADVISORY VOTE TO APPROVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICER AS DISCLOSED IN THE PROXY STATEMENTForABSTAIN — 2 of 3 Brighthouse fundsFor—
Kaiser Aluminum Corporation2026-06-04APPROVAL OF AMENDMENT AND RESTATEMENT OF KAISER ALUMINUM CORPORATION 2021 EQUITY AND INCENTIVE COMPENSATION PLANForABSTAIN — 2 of 3 Brighthouse fundsFor—
Kaiser Aluminum Corporation2026-06-04RATIFICATION OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026ForABSTAIN — 2 of 3 Brighthouse fundsFor—
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Dana WolfForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 97.5% support
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Dhrupad TrivediForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 95.7% support
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Eric SingerForWITHHOLD — 2 of 3 Brighthouse fundsForPlurality election, 47.7% support
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Peter Y. ChungForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 83.0% support
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Tor R. BrahamForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 97.6% support
Trupanion, Inc.2026-06-10To approve, on a non-binding advisory basis, the compensation provided to our named executive officers for the year ended December 31, 2025.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.3% support
Trupanion, Inc.2026-06-10To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Darryl RawlingsForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.2% support
Trupanion, Inc.2026-06-10To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Elizabeth McLaughlinForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.4% support
Trupanion, Inc.2026-06-10To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Howard RubinForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 98.3% support
Trupanion, Inc.2026-06-10To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Jacqueline DavidsonForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.8% support
Trupanion, Inc.2026-06-10To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Margaret ToothForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.8% support
Trupanion, Inc.2026-06-10To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Murray LowForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 98.3% support
Trupanion, Inc.2026-06-10To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Paulette DodsonForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 98.9% support
Trupanion, Inc.2026-06-10To elect nine directors to hold office until our 2027 Annual Meeting of Stockholders: Richard EnthovenForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.6% support
Trupanion, Inc.2026-06-10To ratify the selection of Ernst & Young LLP as Trupanion, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.8% support
MillerKnoll, Inc.2025-10-13Proposal to approve, on an advisory basis, the Company's Named Executive Officer compensation.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 95.6% support
MillerKnoll, Inc.2025-10-13Proposal to ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.1% support
Walker & Dunlop, Inc.2026-05-19Election of Directors: Dana L. SchmaltzForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.0% support
Walker & Dunlop, Inc.2026-05-19Election of Directors: Donna WellsForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 93.0% support
Walker & Dunlop, Inc.2026-05-19Election of Directors: Ellen LevyForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 94.5% support
Walker & Dunlop, Inc.2026-05-19Election of Directors: Ernest FreedmanForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.6% support
Walker & Dunlop, Inc.2026-05-19Election of Directors: Jeffrey R. HaywardForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.9% support
Walker & Dunlop, Inc.2026-05-19Election of Directors: John RiceForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 96.8% support
Walker & Dunlop, Inc.2026-05-19Election of Directors: William M. WalkerForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 98.6% support
Artivion, Inc.2026-05-12ELECTION OF DIRECTORS: Elizabeth A. HoffForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 95.2% support
Artivion, Inc.2026-05-12ELECTION OF DIRECTORS: Jeffrey H. BurbankForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 87.1% support
Artivion, Inc.2026-05-12ELECTION OF DIRECTORS: Jon W. SalvesonForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 94.9% support
Artivion, Inc.2026-05-12ELECTION OF DIRECTORS: Marna P. BorgstromForWITHHOLD — 2 of 3 Brighthouse fundsForElected, 95.2% support
QuinStreet, Inc.2025-10-30Approval, by advisory vote, of the compensation awarded to QuinStreet, Inc.'s named executive officers as disclosed in the proxy statement.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 97.3% support
QuinStreet, Inc.2025-10-30Election of Directors: David PauldineForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 97.9% support
QuinStreet, Inc.2025-10-30Election of Directors: James SimonsForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 88.4% support
QuinStreet, Inc.2025-10-30Election of Directors: Stuart M. HuizingaForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 99.0% support
QuinStreet, Inc.2025-10-30Ratification of the appointment of PricewaterhouseCoopers LLP as QuinStreet, Inc.'s independent registered public accounting firm for the fiscal year ending June 30, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 98.7% support
Grid Dynamics Holdings, Inc.2025-12-23The approval of 3,500,000 additional shares under the Grid Dynamics Holdings, Inc. 2020 Equity Incentive Plan.AgainstFOR — 2 of 3 Brighthouse fundsForApproved, 68.4% support
Grid Dynamics Holdings, Inc.2025-12-23The approval, on a non-binding advisory basis, of the compensation of our named executive officers.AgainstFOR — 2 of 3 Brighthouse fundsForApproved, 56.8% support
Harmonic Inc.2026-06-04Election of Directors: Dana CrandallForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.5% support
Harmonic Inc.2026-06-04Election of Directors: David KrallForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.5% support
Harmonic Inc.2026-06-04Election of Directors: Deborah L. CliffordForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.4% support
Harmonic Inc.2026-06-04Election of Directors: Neel DevForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.7% support
Harmonic Inc.2026-06-04Election of Directors: Nimrod Ben-NatanForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.7% support
Harmonic Inc.2026-06-04Election of Directors: Patrick GallagherForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 97.6% support
Harmonic Inc.2026-06-04Election of Directors: Stephanie CopelandForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 99.6% support
Harmonic Inc.2026-06-04To approve, on an advisory basis, the compensation of the named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 97.2% support
Harmonic Inc.2026-06-04To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.8% support
Janux Therapeutics, Inc.2026-06-11To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 90.3% support
Janux Therapeutics, Inc.2026-06-11To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.8% support
Syndax Pharmaceuticals, Inc.2026-06-10To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan.AgainstFOR — 2 of 3 Brighthouse fundsFor—
Wave Life Sciences Ltd.2025-08-05The election of the nominees for director: Christian HenryForAGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 85.4% support
Wave Life Sciences Ltd.2025-08-05The election of the nominees for director: Ken TakanashiForAGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 95.4% support
Hertz Global Holdings, Inc.2026-05-28Approval, on an advisory basis, of the compensation of our named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 98.3% support
Hertz Global Holdings, Inc.2026-05-28Election of the two director nominees identified in the Company's Proxy Statement to serve as directors for the three-year term expiring at the Company's 2029 annual meeting of stockholders: Lucy Clark DoughertyForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 98.9% support
Hertz Global Holdings, Inc.2026-05-28Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.1% support
Aclaris Therapeutics, Inc.2026-06-04To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Aclaris Therapeutics, Inc. for its fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.9% support
Verra Mobility Corporation2026-05-19Approve, on an advisory basis (non-binding), the frequency of future advisory votes approving the compensation of our named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsFor—
CSG Systems International, Inc.2026-01-30To adjourn the special meeting from time to time, if necessary or appropriate, as determined in accordance with the merger agreement by the CSG board of directors, including for the purpose of soliciting additional votes for the approval of the merger proposal if there are insufficient votes at the ForABSTAIN — 2 of 3 Brighthouse fundsFor—
CSG Systems International, Inc.2026-01-30To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to named executive officers of CSG in connection with the consummation of the merger; andForABSTAIN — 2 of 3 Brighthouse fundsForPassed (calculated), 68.9% support
Navient Corporation2026-06-04Approve, in a non-binding advisory vote, the compensation paid to Navient-named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 97.3% support
Navient Corporation2026-06-04Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Anna Escobedo CabralForABSTAIN — 2 of 3 Brighthouse fundsForElected, 97.7% support
Navient Corporation2026-06-04Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: David L. YowanForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.4% support
Navient Corporation2026-06-04Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Edward J. BramsonForABSTAIN — 2 of 3 Brighthouse fundsForElected, 98.1% support
Navient Corporation2026-06-04Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Frederick ArnoldForABSTAIN — 2 of 3 Brighthouse fundsForElected, 97.3% support
Navient Corporation2026-06-04Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Larry A. KlaneForABSTAIN — 2 of 3 Brighthouse fundsForElected, 94.2% support
Navient Corporation2026-06-04Elect the 6 nominees named in the proxy statement to serve as directors for one-year terms or until their successors have been duly elected and qualified: Michael A. LawsonForABSTAIN — 2 of 3 Brighthouse fundsForElected, 96.9% support
Navient Corporation2026-06-04Ratify the appointment of KPMG LLP as Navient independent registered public accounting firm for 2026ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 99.2% support
NV5 Global, Inc.2025-07-31To approve, on a non-binding, advisory basis, the compensation that will or may be paid to NV5's named executive officers in connection with the transactions contemplated by the Merger Agreement; and.ForABSTAIN — 2 of 3 Brighthouse fundsForApproved, 94.5% support
The RealReal, Inc.2026-06-10Approval of a management proposal to amend our Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to the Delaware General Corporation Law.ForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsFor—

Download all 381 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 92.2% of this fund’s 14,390 such votes could be given a sector; the other 1,121 (7.8%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance3,0582638.6%
Consumer Discretionary2,47229712.0%
Health Care2,24944119.6%
Industrials1,4591218.3%
Technology1,35122116.4%
Real Estate838779.2%
Energy598549.0%
Utilities373174.6%
Consumer Staples2504919.6%
Basic Materials236145.9%
Miscellaneous2012110.4%
Telecommunications1843519.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections9,7571,408
Say-on-Pay1,700197
Audit-related1,6700
Compensation582182
Corporate Governance41750
Extraordinary Transactions19113
Capital Structure17724
Shareholder Rights and Defenses463
Other130
Other Social Issues30

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Bloom Energy CorporationMay 21, 2026$12M82
Guardant Health, Inc.June 17, 2026$6M52
agilon health, inc.March 17, 2026$5M20
Nextracker Inc.August 18, 2025$5M51
Glaukos CorporationMay 28, 2026$4M41
The Ensign Group, Inc.May 13, 2026$3M60
UMB Financial CorporationApril 28, 2026$3M170
Watts Water Technologies, Inc.May 19, 2026$3M116

Notable votes against management

MeetingCompanyProposalFundMgmt
May 21, 2026Bloom Energy CorporationElection of our four Class II Directors: Barbara BurgerWithholdFor
May 21, 2026Bloom Energy CorporationElection of our four Class II Directors: Eddy ZervigonWithholdFor
June 17, 2026Guardant Health, Inc.Election of Class II Directors: Ian ClarkWithholdFor
June 17, 2026Guardant Health, Inc.Election of Class II Directors: Manuel Hidalgo MedinaWithholdFor
August 18, 2025Nextracker Inc.The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Jeffrey GuldnerWithholdFor
May 28, 2026Glaukos CorporationElection of Directors: Denice M. TorresWithholdFor
May 19, 2026Watts Water Technologies, Inc.Election of Directors: Rebecca J. BollWithholdFor
May 19, 2026Watts Water Technologies, Inc.Election of Directors: Michael J. DuboseWithholdFor
May 29, 2026SiTime CorporationTo approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement.AgainstFor
June 11, 2026TG Therapeutics, Inc.Election of Directors: Laurence CharneyWithholdFor
June 11, 2026TG Therapeutics, Inc.Election of Directors: Yann EchelardWithholdFor
May 21, 2026BrightSpring Health Services, Inc.Election of Class II directors: Olivia KirtleyWithholdFor

Contested meetings

Meetings with a proxy contest or competing nominees (12 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

14,562 ballot items at 1,845 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, MetLife Russell 2000 Index Portfolio voted at 1,845 shareholder meetings of 1,746 companies, on 14,562 ballot items in all. Where management made a recommendation, the fund followed it on 86.9% of the items and voted against it 1,879 times. Its most frequent area of disagreement was director elections (1,408 of its votes against management). It voted on 76 shareholder proposals. It voted FOR the board's own proposals more often than Brighthouse's funds as a whole (86.9% against 76.3%). It voted differently from most Brighthouse funds on 381 items. 12 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Brighthouse’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.